Daniel Billen
Chairman bei AURINIA PHARMACEUTICALS INC.
Vermögen: 167 299 $ am 31.03.2024
Profil
Daniel G.
Billen's current job is Chairman at Aurinia Pharmaceuticals, Inc. His former jobs include Vice President & General Manager at Amgen, Inc., General Manager at Amgen Canada, Inc., and Head-Marketing & Sales at Janssen, Inc. He holds a doctorate degree from Université Catholique de Louvain.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 23.05.2023 | 33 393 ( 0,02% ) | 167 299 $ | 31.03.2024 |
Aktive Positionen von Daniel Billen
| Unternehmen | Position | Beginn |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Chairman | 18.08.2023 |
Ehemalige bekannte Positionen von Daniel Billen
| Unternehmen | Position | Ende |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01.01.2018 |
Amgen Canada, Inc.
 Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Corporate Officer/Principal | 01.01.2011 |
Janssen, Inc.
 Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Sales & Marketing | 01.01.1991 |
Ausbildung von Daniel Billen
| Université Catholique de Louvain | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Amgen Canada, Inc.
Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Health Technology |
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Health Technology |
